ArticleVaccines2022

Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain.

Jesús Ruiz-Aragón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.